Ross Osborn
Stock Analyst at Cantor Fitzgerald
(1.99)
# 2,858
Out of 4,829 analysts
105
Total ratings
30.21%
Success rate
-4.67%
Average return
Main Sectors:
Stocks Rated by Ross Osborn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SIBN SI-BONE | Reiterates: Overweight | $25 | $18.49 | +35.21% | 9 | May 6, 2025 | |
| NNOX Nano-X Imaging | Maintains: Overweight | $12 → $9 | $5.24 | +71.76% | 11 | Apr 1, 2025 | |
| SMTI Sanara MedTech | Reiterates: Overweight | $46 | $32.25 | +42.64% | 6 | Mar 26, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Overweight | $2 | $1.13 | +76.99% | 5 | Mar 26, 2025 | |
| ELUT Elutia | Reiterates: Overweight | $8 | $2.04 | +293.12% | 10 | Mar 7, 2025 | |
| AXGN Axogen | Reiterates: Overweight | $24 | $11.37 | +111.17% | 3 | Mar 5, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $19 → $20 | $12.95 | +54.50% | 5 | Mar 5, 2025 | |
| MDXG MiMedx Group | Reiterates: Overweight | $13 | $7.05 | +84.40% | 3 | Feb 27, 2025 | |
| CERS Cerus | Reiterates: Overweight | $4 | $1.29 | +211.28% | 4 | Feb 21, 2025 | |
| PRE Prenetics Global | Reiterates: Overweight | $9 | $5.39 | +67.05% | 7 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $8 | $5.71 | +40.11% | 5 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $4.21 | +113.78% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $21 | $6.97 | +201.29% | 10 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $6.21 | +157.65% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $14 | $4.77 | +193.50% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $96 | $80.26 | +19.61% | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $3.5 | $1.12 | +212.50% | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $2.5 | $0.50 | +400.00% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.45 | - | 7 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $3.06 | +63.40% | 2 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $8.61 | $0.68 | +1,162.65% | 2 | Aug 18, 2023 |
SI-BONE
May 6, 2025
Reiterates: Overweight
Price Target: $25
Current: $18.49
Upside: +35.21%
Nano-X Imaging
Apr 1, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $5.24
Upside: +71.76%
Sanara MedTech
Mar 26, 2025
Reiterates: Overweight
Price Target: $46
Current: $32.25
Upside: +42.64%
Lucid Diagnostics
Mar 26, 2025
Reiterates: Overweight
Price Target: $2
Current: $1.13
Upside: +76.99%
Elutia
Mar 7, 2025
Reiterates: Overweight
Price Target: $8
Current: $2.04
Upside: +293.12%
Axogen
Mar 5, 2025
Reiterates: Overweight
Price Target: $24
Current: $11.37
Upside: +111.17%
NeuroPace
Mar 5, 2025
Maintains: Overweight
Price Target: $19 → $20
Current: $12.95
Upside: +54.50%
MiMedx Group
Feb 27, 2025
Reiterates: Overweight
Price Target: $13
Current: $7.05
Upside: +84.40%
Cerus
Feb 21, 2025
Reiterates: Overweight
Price Target: $4
Current: $1.29
Upside: +211.28%
Prenetics Global
Jan 16, 2025
Reiterates: Overweight
Price Target: $9
Current: $5.39
Upside: +67.05%
Jan 13, 2025
Reiterates: Overweight
Price Target: $8
Current: $5.71
Upside: +40.11%
Jan 7, 2025
Initiates: Overweight
Price Target: $9
Current: $4.21
Upside: +113.78%
Dec 24, 2024
Reiterates: Overweight
Price Target: $21
Current: $6.97
Upside: +201.29%
Nov 5, 2024
Reiterates: Overweight
Price Target: $16
Current: $6.21
Upside: +157.65%
Oct 23, 2024
Reiterates: Overweight
Price Target: $14
Current: $4.77
Upside: +193.50%
Oct 15, 2024
Initiates: Neutral
Price Target: $96
Current: $80.26
Upside: +19.61%
Aug 8, 2024
Reiterates: Overweight
Price Target: $3.5
Current: $1.12
Upside: +212.50%
May 16, 2024
Reiterates: Overweight
Price Target: $2.5
Current: $0.50
Upside: +400.00%
Apr 12, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.45
Upside: -
Mar 1, 2024
Reiterates: Overweight
Price Target: $5
Current: $3.06
Upside: +63.40%
Aug 18, 2023
Reiterates: Neutral
Price Target: $8.61
Current: $0.68
Upside: +1,162.65%